|
UBE2T expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40432110384836E-12 |
| Normal-vs-Stage2 |
4.084300E-03 |
| Normal-vs-Stage3 |
1.10140000009196E-07 |
| Normal-vs-Stage4 |
1.035650E-02 |
| Stage1-vs-Stage2 |
3.392200E-01 |
| Stage1-vs-Stage3 |
3.027600E-04 |
| Stage1-vs-Stage4 |
5.815800E-02 |
| Stage2-vs-Stage3 |
2.708400E-02 |
| Stage2-vs-Stage4 |
1.146350E-01 |
| Stage3-vs-Stage4 |
5.517000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.77250003352958E-09 |
| Normal-vs-Asian |
8.200200E-03 |
| Caucasian-vs-AfricanAmerican |
6.157400E-01 |
| Caucasian-vs-Asian |
1.407360E-01 |
| AfricanAmerican-vs-Asian |
4.210400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.61079951996624E-10 |
| Male-vs-Female |
5.960900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.57890000002303E-06 |
| Normal-vs-Extreme_Weight |
6.23334717175794E-12 |
| Normal-vs-Obese |
4.49430004323403E-09 |
| Normal-vs-Extreme_Obese |
4.678200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.234800E-01 |
| Normal_Weight-vs-Obese |
6.841600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.028370E-02 |
| Extreme_Weight-vs-Obese |
1.350010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.370500E-02 |
| Obese-vs-Extreme_Obese |
5.921100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.821000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.1538326677728E-14 |
| Normal-vs-Age(61-80Yrs) |
1.78912440418344E-12 |
| Normal-vs-Age(81-100Yrs) |
8.626600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.464200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.787790E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.620800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.988400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.085560E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.293600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62481139653892E-12 |
| Normal-VS-Type2 PRCC |
1.78860004584891E-09 |
| Normal-VS-KIRP CIMP |
2.26829999999678E-05 |
| Normal-VS-Unclassified PRCC |
6.32419999999634E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.644480E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.370580E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.601400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.29510000004929E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.257390E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.89399995687012E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.99710000045894E-08 |
| Normal-vs-N1 |
4.20349999996628E-06 |
| Normal-vs-N2 |
1.119400E-01 |
| N0-vs-N1 |
1.435680E-03 |
| N0-vs-N2 |
2.570400E-01 |
| N1-vs-N2 |
9.075400E-01 |
|
|
